Patrick A. Ott

Also affiliated with Harvard University, Dana-Farber Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study”.

Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study

Cancer(2020)10.1002/cncr.32883

N/A

4.9DataRank · unranked

150 citations

Emily Bergsland, Bert H. O’Neil, Armando Santoro, Jan H.M. Schellens, Roger B. Cohen +15 more

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

Nature Medicine(2021)10.1038/s41591-020-01206-4

N/A

4.5DataRank · unranked

525 citations

Donna Leet, Rosa Lundbye Allesøe, Giacomo Oliveira, Shuqiang Li, Adrienne Luoma +36 more

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00382-4

N/A

2.2DataRank · unranked

73 citations

Philippe A. Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoîne Italiano +17 more

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Nature(2018)10.1038/s41586-018-0792-9

N/A

1.1DataRank · unranked

1412 citations

Jing Sun, Itay Tirosh, Nathan D. Mathewson, Shuqiang Li, Giacomo Oliveira +51 more

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002446

N/A

1.0DataRank · unranked

26 citations

Omid Hamid, Elisabeth G.E. de Vries, Patrick A. Ott, Javier García-Corbacho, Valentina Boni +8 more

Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

Nature(2021)10.1038/s41586-021-03704-y

N/A

0.951DataRank · unranked

566 citations

Kari Stromhaug, Susan Klaeger, Tomasz Kula, Dennie T. Frederick, Phuong M. Le +21 more

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy

Scientific Reports(2020)10.1038/s41598-019-56943-5

N/A

0.912DataRank · unranked

32 citations

Rebecca L. Holden, Binyou Wang, Pu‐Guang Chen, Stephanie Hanna, Zhuting Hu +9 more

Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples

Molecular & Cellular Proteomics(2021)10.1016/j.mcpro.2021.100133

N/A

0.609DataRank · unranked

57 citations

Annie Apffel, Karl R. Clauser, Siranush Sarkizova, Giacomo Oliveira, Suzanna Rachimi +12 more

Nivolumab (NIVO) + tacrolimus (TACRO) + prednisone (PRED) +/- ipilimumab (IPI) for kidney transplant recipients (KTR) with advanced cutaneous cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9507

N/A

0.434DataRank · unranked

17 citations

Julie E. Stein, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I. Khushalani +13 more

Optimized liquid and gas phase fractionation increase HLA-peptidome coverage for primary cell and tissue samples

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.25.445487

N/A

0.104DataRank · unranked

1 citations

Annie Apffel, Karl R. Clauser, Siranush Sarkizova, Giacomo Oliveira, Suzanna Rachimi +12 more

Selection of targeted neoantigens for ongoing personalized cancer vaccine trials at Dana Farber Cancer Institute 2189

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.138

N/A

0DataRank · unranked

0 citations

David A. Braun, Cleo Forman, Chloe Ran Tu, Siranush Sarkizova, Nir Hacohen +4 more

Directing Traffic: How to Effectively Drive T Cells into Tumors

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0790

N/A

0DataRank · unranked

115 citations

Catherine J. Wu, Patrick A. Ott, Annabelle Anandappa

A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3158

N/A

0DataRank · unranked

6 citations

María E. Suarez‐Almazor, Jeane Painter, Tanner M. Johanns, Michael Dougan, Laura C. Cappelli +15 more

A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps2676

N/A

0DataRank · unranked

29 citations

Michael Dougan, Sarthak Gupta, Laura C. Cappelli, Tamiko R. Katsumoto, Osama E. Rahma +15 more

Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy

Nature Communications(2023)10.1038/s41467-023-37230-4

N/A

0DataRank · unranked

30 citations

Daniel DiToro, Joel Henderson, Sujal I. Shah, Mike Manos, Mariano Severgnini +6 more

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

Cell(2025)10.1016/j.cell.2025.06.019

N/A

0DataRank · unranked

30 citations

Derin B. Keskin, Chloe Ran Tu, Cleo Forman, Allison P. Vanasse, Haley E. Sax +39 more

ATIM-32. PERSONALIZED NEOANTIGEN-TARGETING VACCINE GENERATES ROBUST SYSTEMIC AND INTRATUMORAL T CELL RESPONSES IN GLIOBLASTOMA (GBM) PATIENTS

Neuro-Oncology(2018)10.1093/neuonc/noy148.027

N/A

0DataRank · unranked

0 citations

Itay Tirosh, Annabelle Anandappa, Jing Sun, Chang‐Jiun Wu, Evisa Gjini +21 more